Home / Brands / Generic Peptides / Generic Peptides CJC-1295 DAC 2 to 10 mg Vials for Sale
Generic Peptides CJC-1295 DAC 2 to 10 mg Vials for Sale
Generic Peptides CJC-1295 DAC 2 to 10 mg Vials for Sale
Generic Peptides CJC-1295 DAC 2 to 10 mg Vials for Sale
Generic Peptides

Generic Peptides CJC-1295 DAC 2 to 10 mg Vials for Sale

Injection · 2 mg · vial

Out of stock
$35.00

Generic Peptides CJC-1295 DAC is a long-acting GHRH analog, a lyophilized peptide secretagogue supplied for laboratory research into the growth hormone and IGF-1 axis. Available for purchase in three vial sizes: 2 mg, 5 mg and 10 mg.

GMP-manufactured, each batch HPLC-verified with the Certificate of Analysis (COA) on file. CJC-1295 DAC for sale with U.S. domestic and international shipping.

Discreet plain packaging
Worldwide reship guarantee
Crypto & card accepted

Product overview

Generic Peptides CJC-1295 DAC - 2 to 10 mg Lyophilized Vials

Generic Peptides CJC-1295 DAC is a synthetic growth hormone releasing hormone analog with a drug affinity complex, or DAC, a lyophilized powder in three vial sizes: 2 mg, 5 mg and 10 mg. It is a secretagogue, so it prompts the body to release its own growth hormone. The DAC anchors the peptide to albumin and stretches one dose over days. Buy CJC-1295 DAC in the size that fits your study, and compare it with the short-acting version, CJC-1295 no DAC, when the design tests release profiles.

  • Three vial sizes - 2 mg, 5 mg and 10 mg
  • Lyophilized powder - needs a solvent
  • GMP-manufactured - HPLC-verified per batch, COA on file
  • U.S. domestic and international shipping

Variant Comparison

All three vials hold the same long-acting peptide and differ only in amount per vial. Because one injection lasts days, the vial size sets how long a study runs.

Variant Dosage Form and quantity Best use
CJC-1295 DAC 2 mg 2 mg per vial Lyophilized vial Short research series
CJC-1295 DAC 5 mg 5 mg per vial Lyophilized vial Standard research runs
CJC-1295 DAC 10 mg 10 mg per vial Lyophilized vial Extended studies

The practical difference is how many weekly injections a vial covers: the 10 mg vial covers an extended run and the 2 mg vial a short one. A common partner is a ghrelin-receptor secretagogue such as GHRP-2 or Ipamorelin.

How CJC-1295 DAC Works

CJC-1295 is a modified form of GHRH(1-29) with a mass of about 3,647 daltons. The DAC group attaches the peptide to plasma albumin, which slows clearance and keeps it active far longer than natural GHRH. A single injection has been reported to raise growth hormone two to ten times for six days or more, and IGF-1 by a factor of 0.5 to 3 for nine to eleven days.

Reconstitution & Storage

CJC-1295 DAC ships as a powder dissolved with sterile or bacteriostatic water, not part of the pack. Divide the milligrams on the vial by the millilitres added to get mg per mL; a 5 mg vial in 2 mL gives 2.5 mg/mL. Keep the powder at 2-8 C, away from light, and do not freeze it. Once mixed, keep it at 2-8 C and use it within 28 to 30 days.

Dosage & Administration

There is no approved dose or dosage form. Its estimated half-life in humans is around six to eight days, so non-medical protocols inject once or twice a week rather than daily. The clinical program reached phase two and was halted in 2006 after the death of a study participant, so long-term human safety data is missing. CJC-1295 sits in WADA class S2 and is banned at all times in sport. Related compounds are Sermorelin and Somatropin.

Supplied for laboratory research only, not for human or veterinary use. Information provided is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before use.

Specifications

Trade NameCJC-1295 DAC
Generic NameCJC-1295 (GHRH analog, with DAC)
ManufacturerGeneric Peptides
Dosage2 mg, 5 mg or 10 mg per vial
PackageLyophilized vial
Drug ClassGHRH secretagogue (growth hormone releasing)
AdministrationSubcutaneous (research protocols)
StorageLyophilized 2-8 C; reconstituted 2-8 C, use in 28-30 days
Prescription StatusResearch use only; not for human use
VerificationBatch details confirmed with supplier
ShippingU.S. domestic + international

Stacks

Long-Acting GH Protocol

CJC-1295 DAC with Ipamorelin, one or two long-acting injections per week paired with a sharp ghrelin pulse.

Expected outcome: a model that contrasts a long flat IGF-1 rise with a short nocturnal GH pulse.

GHRH and Ghrelin Stack

CJC-1295 DAC with GHRP-2, the classic long-acting GHRH analog plus a ghrelin-receptor secretagogue.

Expected outcome: a design that studies whether a sustained signal and a triggered pulse add up over the same window.

Release Profile Comparison

CJC-1295 DAC against CJC-1295 no DAC, run as two groups to compare a long signal with a short one.

Expected outcome: a side-by-side read-out of an albumin-bound analog and the same backbone without the DAC anchor.

For laboratory research only. Consult a healthcare professional before handling any peptide. Amounts shown are research references, not recommended human doses.

FAQ

Before you ask

Questions, answered

CJC-1295 DAC is a synthetic growth hormone releasing hormone analog built from GHRH(1-29) with a drug affinity complex attached. The DAC links the peptide to albumin in the blood, which slows its clearance and stretches one dose over days. It is a secretagogue, so it signals the body to release its own growth hormone rather than supplying the hormone.

A single injection has been reported to raise growth hormone two to ten times for six days or more, and IGF-1 by a factor of 0.5 to 3 for nine to eleven days. Repeated dosing can keep IGF-1 elevated for up to 28 days. Its estimated human half-life is around six to eight days, though reviews give a range of about 5.8 to 8.1 days.

Add sterile or bacteriostatic water down the vial wall and swirl gently until the powder dissolves. Divide the milligrams on the vial by the millilitres added to get mg per mL. A 5 mg vial with 2 mL gives 2.5 mg/mL, so one unit on a U-100 barrel equals 0.01 mL. Keep the mixed solution at 2-8 C and use it within 28 to 30 days.

Because the DAC extends the half-life to days, non-medical research protocols inject once or twice a week rather than daily. There is no approved dose. Note that a flat, sustained rise in IGF-1 is not the same as the body's natural pulsatile release, and monitoring IGF-1 is part of careful study design.

The clinical development program for lipodystrophy and growth hormone deficiency reached phase two and was halted in 2006 after the death of a study participant. Because of that, and because the program never continued, there is no long-term human safety dataset for the compound. That gap is why the product is described as research material only.

With no approved form or long-term safety data, the main warning is the absence of evidence, not a list of known effects. Raised growth hormone and IGF-1 carry their own risk profile over time. CJC-1295 sits in class S2 of the WADA Prohibited List as a growth hormone releasing factor and is banned at all times in sport, so check the rules that apply to you.

All three vial sizes are listed here as lyophilized research material, with U.S. domestic and international shipping at checkout. Check the import rules that apply where you live before ordering. This listing is for information and is not a substitute for a consultation.

No reviews yet

Be the first to share your experience with Generic Peptides CJC-1295 DAC 2 to 10 mg Vials for Sale

Log in to write a review

Complete the cycle

Stack it with

View all